CHICAGO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Q-Centrix®, the largest exclusive provider of clinical data management solutions to hospitals and health systems, today announced the launch of the first and only comprehensive oncology data solution in the market—the Q-Centrix Oncology Platform—to streamline the process of capturing and submitting oncology clinical data, ultimately empowering oncology leadership to unlock the value of that data.
Featuring the same revolutionary technology that drives the industry-leading eCDM™ platform with SOC 2 + HITRUST Security Assessment, the Q-Centrix Oncology Platform leverages the capabilities of Q-Centrix's team of Certified Tumor Registrar (CTR) experts and intuitive analytics to return meaningful, high-fidelity, and secure clinical cancer data insights in real-time, which can be used to improve patient outcomes and support accreditations.
The comprehensive oncology solution provides hospitals and health systems with modern clinical data infrastructure that will allow them to capture and analyze patient data in real-time, sort through the years’ worth of clinical data backlogs that existed pre-pandemic due to lack of resources, and meet the new rapid reporting requirements for oncology registry data—all of which becomes especially critical as cancer departments across the country anticipate an influx of new cancer cases in the coming months due to pandemic-induced screening delays.

Ad Statistics
Times Displayed: 345944
Times Visited: 21062 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
"Oncology programs throughout the country are facing a tremendous challenge as a result of the new rapid reporting system for oncology registry data that was put into place last year. As the oldest registry in the market, this required a complete overhaul of protocols that had been in place, presenting a need for concurrent abstraction and the opportunity to transform cancer data management programs with more current data," said Brian Foy, Chief Product Officer at Q-Centrix. "By adding oncology capabilities to our existing eCDM™ technology, we now have the solution to the challenge many oncology programs are facing by offering people, process, and technology to ensure data integrity and availability.
Q-Centrix's oncology platform ensures hospitals get the most from their clinical data by pinpointing performance improvement and revenue growth opportunities across health systems. Key features include:
State-of-the-art clinical and operational analytics: Quickly identify opportunities through next-generation analytics—including pre-and-post surgery, aggregated patient migration metrics, and trending on treatment modality volumes both at a facility and system level—while driving improvement through best practices with support from a Dedicated Advisor.